D’Armiento, J., Shiomi, T., Marks, S., Geraghty, P., Sankarasharma, D., & Chada, K. (2016). Mesenchymal tumorigenesis driven by TSC2 haploinsufficiency requires HMGA2 and is independent of mTOR pathway activation. Cancer Res.
Citação norma ChicagoD’Armiento, Jeanine, Takayuki Shiomi, Sarah Marks, Patrick Geraghty, Devipriya Sankarasharma, and Kiran Chada. "Mesenchymal Tumorigenesis Driven By TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of MTOR Pathway Activation." Cancer Res 2016.
MLA CitationD’Armiento, Jeanine, et al. "Mesenchymal Tumorigenesis Driven By TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of MTOR Pathway Activation." Cancer Res 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.